Range
3.95 - 4.27
Vol / Avg.
271.4K/-
Div / Yield
-
52 Wk
- - -
Mkt Cap
87.1M
Payout Ratio
-
Open
4.25
P/E
-
EPS
-1.01
Shares
21.7M
Outstanding
21.7M
Total Float
-
Clarus Therapeutics Holdings Inc is a pharmaceutical company with expertise in developing androgen and metabolic therapies for men and women, including potential therapies for orphan indications. The company's first commercial product is JATENZO.

Earnings

see more
Q3 2021Est.ActualSurprise
EPS
(EXPECTED)2021-11-05
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Clarus Therapeutics Hldgs Questions & Anwsers

Q

How do I buy Clarus Therapeutics Hldgs (CRXT) stock?

A

You can purchase shares of Clarus Therapeutics Hldgs (NASDAQ: CRXT) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Clarus Therapeutics Hldgs's (CRXT) competitors?

A

There are no as such competitors for Clarus Therapeutics Hldgs.

Q

What is the target price for Clarus Therapeutics Hldgs (CRXT) stock?

A

The latest price target for Clarus Therapeutics Hldgs (NASDAQ: CRXT) was reported by Truist Securities on October 13, 2021. The analyst firm set a price target for 10.00 expecting CRXT to rise to within 12 months (a possible 149.38% upside). 5 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Clarus Therapeutics Hldgs (CRXT)?

A

The stock price for Clarus Therapeutics Hldgs (NASDAQ: CRXT) is $4.01 last updated Mon Oct 25 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

Does Clarus Therapeutics Hldgs (CRXT) pay a dividend?

A

There are no upcoming dividends for Clarus Therapeutics Hldgs.

Q

When is Clarus Therapeutics Hldgs (NASDAQ:CRXT) reporting earnings?

A

Clarus Therapeutics Hldgs’s $Q3 earnings are confirmed for after-market on $November 5, 2021.

Q

Is Clarus Therapeutics Hldgs (CRXT) going to split?

A

There is no upcoming split for Clarus Therapeutics Hldgs.

Q

What sector and industry does Clarus Therapeutics Hldgs (CRXT) operate in?

A

Clarus Therapeutics Hldgs is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.